Tangshan People's Hospital

Tangshan People's Hospital was founded in 1943 and is the earliest public hospital in Tangshan. In the 1960s and 1970s, the orthopedics, traditional Chinese medicine, and tuberculosis prevention departments of the hospital were established and established, including the Municipal Orthopedics Hospital, the Municipal Traditional Chinese Medicine Hospital, the Municipal Infectious Disease Hospital, and the Municipal Third Hospital. It can be said that the history of the People's Hospital is also the development history of Tangshan's health industry, which has trained a large number of professional and technical talents for the development of Tangshan's health industry. It is hailed as the "mother of hospitals" by industry insiders and is the cradle of Tangshan's health industry development. The hospital covers an area of over 50000 square meters, with 1040 designated beds and 1380 open beds. It has 51 clinical departments, 15 medical technology departments, and 44 inpatient wards. The hospital has 10 medical centers, including Tangshan Cancer Diagnosis and Treatment Center, Breast Disease Prevention and Control Center, Tangshan International Cancer Consultation Center between China and the United States, Tumor Radiotherapy Center, Stroke Center, and Vertigo Treatment and Rehabilitation Center. There are 1 provincial-level key discipline, 2 provincial-level key cultivation specialties, 1 provincial-level key specialty construction unit, 1 provincial-level key laboratory, 11 municipal key disciplines, and 1 municipal tumor research institute. The annual outpatient volume is nearly 500000 people, with over 55000 discharged patients and 18500 surgeries carried out. In 2002, it was one of the first batch of hospitals in Hebei Province and the first to pass the ISO9000 international quality certification system in Tangshan City. It is a large-scale comprehensive tertiary first-class hospital that integrates medical treatment, teaching, scientific research, preventive health care, and rehabilitation, with tumor treatment as its characteristics. It is now an affiliated hospital of North China University of Technology and a nursing home of Tangshan People's Hospital under the Li Ka shing Foundation. The hospital has been designated as a "national drug clinical trial institution", a national "million women's breast screening project unit", and a national health management demonstration base unit. It is a training base for Anning treatment and nursing in Hebei Province, a "standardized training demonstration base for general practitioners in Hebei Province", a provincial-level academician workstation in Hebei Province, a Chinese medicine master studio, and a postdoctoral innovation practice base in Hebei Province. In recent years, the hospital has adhered to the strategy of "revitalizing the hospital through science and technology", relying on basic research and clinical application research as the main body. It attaches importance to scientific research management, talent cultivation, and team building, with significant achievements and a steady improvement in academic level. In recent years, I have led 5 National Natural Science Foundation Youth Fund projects and participated in 4 provincial and ministerial level scientific research projects. 15 projects have successively won 1 first prize, 3 second prizes, and 4 municipal and ministerial level awards in Hebei Province. Published 768 papers in SCI and national core journals. Among them, there are 82 SCI articles, with a single article having the highest impact factor of 14.695. The hospital has 2270 employees, including 363 personnel with senior technical titles, 420 with doctoral and master's degrees, 1 doctoral supervisor, and 33 master's supervisor. This has formed a scientific, comprehensive, and reasonable talent pool that is in line with the long-term development of the hospital. Hospitals pay attention to connotation construction in management, adhere to the policy of "People's Hospital for the People", establish the service concept of "patients' needs are our pursuit", focus on patients, strengthen hospital culture construction, implement humanized services, and receive good social benefits. The hospital has successively won many honors, such as the "National Demonstration Hospital for People's Confidence", the "National Advanced Collective for Earthquake Relief in the Health System", the "National Advanced Collective for Hospital Culture", the "National Women's Demonstration Post", the "National Excellent Achievement Award for Hospital Culture Construction", the "Civilized Unit of Hebei Province", and the "Integrity Hospital of Hebei Province". In recent years, the hospital has made efforts to strengthen external cooperation and exchange, following the principle of "please come in, go out", and seeking cooperation opportunities with large medical institutions and research institutes in Beijing, Tianjin, and even abroad. It has explored the use of various cooperation models, built external medical cooperation platforms, and achieved mutual docking and integration of medical resources, so that more patients can enjoy convenient, high-quality, and efficient medical services. The hospital has engaged in in-depth cooperation with large tertiary hospitals such as the Third Hospital of Beijing Medical University, Beijing Tiantan Hospital, the Second Artillery General Hospital of the People's Liberation Army, and the Cancer Hospital of the Chinese Academy of Sciences in various aspects such as the current development status of the discipline, the establishment of cooperation platforms, the cultivation of discipline talents, the feasibility of cooperation projects, and the establishment of a two-way referral mechanism. In addition, we have established an international consultation mechanism with the top 50 large medical institutions in the United States - the Tangshan International Consultation Center between China and the United States, providing "international medical" and "medical exchanges" between China and the United States, and providing comprehensive consultation and diagnosis and treatment guidance. And regularly conduct academic exchanges and visits with top medical institutions in Germany, Japan, Sweden and other countries, absorb high-quality medical resources from abroad, and further improve the level of diagnosis and treatment of difficult and severe tumors. With the continuous deepening of communication and cooperation, the hospital has successfully hosted and hosted multiple national, provincial, and municipal level large-scale academic conferences, such as the National Cancer Hospital Alliance Annual Meeting (2016), the National Humanities and Palliative Care Conference (2017), the Youth Committee of the Cancer Psychology Professional Committee of the China Anti Cancer Association Visiting Tangshan Station (2016), and the Second Tianjin Beijing Hebei Thyroid Cancer Summit Forum (2018) The 10th Hebei Cancer Academic Conference (2014), Hebei Cancer Radiotherapy Academic Annual Conference (2015), Sino US Orthopaedics International Exchange Academic Seminar (2015-2019), Sino US Colorectal Cancer International Exchange Seminar (2016), Sino US International Symposium on Standardized Diagnosis and Treatment of Breast Cancer (2017), Sino British International breast cancer Forum (2019), the first International Summit Forum on Precision Diagnosis and Treatment of breast cancer (2019), etc, The event allows healthcare professionals and Tangshan residents in our city to enjoy domestic and international first-class diagnostic and treatment concepts, academic cutting-edge, and high-end diagnostic and treatment technologies without leaving the city. Introduced foreign experts include Cui Quanjun, an orthopedic expert from the University of Virginia School of Medicine, William C. Foster, David Weiss, Dr. Diduch, Rose University of the United States, and Margaret Thompson from the University of Atlanta, Florida, as well as ArturoLoaiza-B, MD, Vice Chairman of the Cancer Department of the Cleveland Clinic Maria Atz American Cancer Treatment Center (CTCA) TouficKachaamy, Director of Interventional Gastroenterology Program at the United States Cancer Treatment Center (CTCA), Georgios Pafitanias, Royal Mary Hospital, Japan Tomoyuki Yano, Shibata Tomoyoshi, KarakawaRyo, Hiroshima University International Lymphedema Treatment Center, Xu Yin, and others.